Zevalin/BEAM/Rituximab vs BEAM/Rituximab With or Without Rituximab in Autologous Stem Cell Transplantation

Clinical trial NCT00591630 · COMPLETED

Trial details

NCT number: NCT00591630
Sponsor: M.D. Anderson Cancer Center
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Diffuse Large Cell Lymphoma Lymphoma

Start date: 2007-11-14
Primary completion: 2020-03-05
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.